There are 1,881 papers on insulin in aging research: 648 trials and 422 observational studies in people, 458 in animals, 20 in cells, 298 reviews.
714 new papers in 30 daysSee all 12,068 papers on insulin
At a glance
Insulin is linked with higher mortality in a human cohort and with cellular senescence in human liver. Human trials report lower insulin with exercise and caloric restriction, while a five-day trial in people with newly detected type 2 diabetes shows no clear effect of metformin or creatine on insulin.
312 findings in 269 papers from 1984 to 2026, 26 of them since April 2026
“After Diet P, only subjects with GG genotype showed a significant improvement in the insulin levels”
- Human trial648
- Humans422
- Animals457
- Model organisms1
- Cells20
- In silico9
Interventions
133Caloric restriction
downin humans6downin mice5downin Mammalia1upin mice1+1−80%
14 studies
Caloric restriction
downin humans6downin mice5downin Mammalia1upin mice1+1−80%
Caloric restriction decreases insulin in humans.
“When repeated measurements were compared, insulin levels were found to be significantly decreased in all obese groups.”
Human trial12-weekfemalesn = 54
The Eurasian journal of medicine
Caloric restriction decreases insulin in humans (P < .05).
“insulin levels in all obese groups decreased significantly (P < .05).”
Human trial12 weeksfemalesn = 54
The Eurasian journal of medicine
Caloric restriction decreases insulin in humans (randomized to CR vs no CR) (mean difference -15.3 pmol/mL (95% CI -8.1, -22.6)).
“CR was associated with significant improvements in CRP and insulin compared to no CR”
Human trialrandomized to CR vs no CR6 months
Caloric Restriction and Changes in Geroscience Blood-Based Biomarkers in Older Adults
GSA 2025 abstract
Caloric restriction decreases insulin in T2D patients.
“CR lowered insulin in T2D patients, whereas glucose, GIP, and GLP-1 were unaffected.”
Human trialin T2D patients
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Caloric restriction decreases insulin in humans (-34% to -38%).
“Following both low energy availability conditions, leptin (-53% to -56%) and insulin (-34% to -38%) were reduced (P < 0.05).”
Human trial15 kcal · kg(-1) fat-free mass [FFM] · day(-1)4-daymalesn = 6
Journal of sports sciences
Caloric restriction decreases insulin in humans (compared with fed state).
“Mean glucose, insulin, and leptin concentrations were lower (P < 0.0001) for CAL-DEP compared to the fully fed (FED) state.”
Human trialcompared with fed state<10% of estimated energy requirements48 h
Obesity (Silver Spring, Md.)
Caloric restriction decreases insulin in mice.
“CR decreased basal insulin concentrations in all age groups”
Animals15%males
Biogerontology
Caloric restriction increases insulin in TejJ89 and TejJ114 relative to AL controls.
“both strains TejJ89 and TejJ114 were hyperinsulinemic following CR relative to their AL controls.”
Animalsin TejJ89 and TejJ114 relative to AL controls10 monthsfemales
Molecular and cellular endocrinology
Caloric restriction decreases insulin in high-fat diet and renal artery stenosis rats (OHR group).
“Reductions in insulinemia, lipids, islets fibrotic areas in the OHR group were observed along with increased insulin sensitivity”
Animalsin high-fat diet and renal artery stenosis rats (OHR group)
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Caloric restriction decreases insulin in mice (CR mice compared with AL-control).
“CR-mice showed lowered cholesterol, insulin and leptin levels”
AnimalsCR mice compared with AL-control
Scientific reports
All 15Fewer
Exercise
downin humans12−40% lower
12 studies
Exercise
downin humans12−40% lower
Exercise prevents insulin in humans.
“There was a significantly greater increase in insulin in the control group compared to the exercise group (p = 0.034), while no significant differences were found for glucose, IGF-1, or IGFBP-1.”
Human trial12-weekfemales
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Exercise prevents insulin in humans during (neo)adjuvant chemotherapy (p = 0.034).
“Exercise prevented the insulin rise observed in controls (p = 0.034).”
Human trialduring (neo)adjuvant chemotherapy12-weekfemales
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Exercise decreases insulin in humans during oral glucose tolerance test.
“Exercise had no effect on glucose following INI, although insulin was reduced during the OGTT (P < 0.05).”
Human trialduring oral glucose tolerance test
American journal of physiology. Regulatory, integrative and comparative physiology
Exercise decreases insulin in humans.
“In addition, insulin was significantly lower after exercise compared with rest during the OGTT (p = 0.004) and the entire protocol (p = 0.007).”
Human trial60 minn = 15
Appetite Perception and Cerebral Blood Flow in Aging Adults Following a Single Bout of Exercise
Nutrients
Exercise decreases insulin in humans (p = 0.007).
“Exercise tended to lower blood glucose (p = 0.072) and plasma insulin (p = 0.007) tAUC, compared with rest.”
Human trialacute exercise (70% maximal oxygen consumption)n = 15
Appetite Perception and Cerebral Blood Flow in Aging Adults Following a Single Bout of Exercise
Nutrients
Exercise decreases insulin in humans.
“Venous glucose, insulin, and HOMA‐IR were lower after exercise relative to the rest condition (p < 0.001, all); however, there were no differences found for venous lactate concentration between rest and exercise conditions (p = 0.27).”
Human trial2 weeksn = 36
Physiological reports
Exercise decreases insulin in humans (p < 0.001).
“Postprandial exercise decreased insulin and glucose in younger and older adults compared to postprandial sitting (p < 0.001, p = 0.003).”
Human trialn = 36
Physiological reports
Exercise is linked with lower insulin in humans (compared with untrained middle-aged adults) (p < 0.05).
“UMA exhibited higher concentrations of leptin, insulin, and resistin”
Humanscompared with untrained middle-aged adultsserummales
European journal of applied physiology
Exercise is linked with lower insulin in humans (active versus sedentary participants, independent of age) (40% lower).
“Active participants had 40% lower insulin concentration and 53% lower FGF21 concentration than sedentary participants”
Humansactive versus sedentary participants, independent of age
Medicine and science in sports and exercise
Exercise decreases insulin in humans (high-frequency interruption strategies).
“High-frequency interruption strategies showed the most favourable acute effects on glucose and insulin responses”
Reviewhigh-frequency interruption strategiesn = 1,369
Journal of sports sciences
All 15Fewer
Resveratrol
downin humans3no changein humans1downin mice1
5 studies
Resveratrol
downin humans3no changein humans1downin mice1
Resveratrol decreases insulin in humans (type 2 diabetes mellitus) (-0.97±1.91, μIU/mL, p=0.02).
“Moreover, the mean difference in insulin levels reached significance (-0.97±1.91, μIU/mL, p= 0.02).”
Human trialtype 2 diabetes mellitusmicronized trans-resveratrol1000 mg/day8 weeksn = 71
Phytotherapy research : PTR
Resveratrol decreases insulin in humans (patients with type 2 diabetes with sample size ≥ 500 and study number ≥ 10).
“significant decline in serum insulin level was observed for sample size ≥ 500 and study number ≥ 10.”
Reviewpatients with type 2 diabetes with sample size ≥ 500 and study number ≥ 10
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Resveratrol showed no clear effect on insulin in individuals with obesity or overweight (SMD = -0.00, 95%CI [-0.25, 0.24], P = 0.97).
“Similarly, no significant effect was observed for insulin levels (SMD = -0.00, 95%CI [-0.25, 0.24], P = 0.97, I2 = 0 %)”
Reviewin individuals with obesity or overweight4-week
Obesity pillars
Resveratrol decreases insulin in mice (high-fat diet-fed mice).
“lowered fasting and post-glucose-bolus insulin levels”
Animalshigh-fat diet-fed mice≈28 mg (dihydro)stilbene kg−1 mouse per day
Molecular nutrition & food research
Resveratrol decreases insulin in T2DM participants (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001).
“and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001).”
Reviewin T2DM participants
Nutrition & metabolism
Dehydroepiandrosterone
no changein humans2downin humans1upin humans1downin mice1+50%
5 studies
Dehydroepiandrosterone
no changein humans2downin humans1upin humans1downin mice1+50%
Dehydroepiandrosterone decreases insulin in humans (hypoadrenal women) (42 +/- 4.94 vs. 53 +/- 6.58 pmol/l [P = 0.005]).
“Fasting plasma insulin and glucagon were lower with DHEA (42 +/- 4.94 vs. 53 +/- 6.58 pmol/l [P = 0.005]”
Human trialhypoadrenal women50-mg12 weeksfemalesn = 28
Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women
Diabetes
Dehydroepiandrosterone showed no clear effect on insulin in humans (hypercholesterolemia).
“In contrast, steady state plasma insulin did not change during the study in either group.”
Human trialhypercholesterolemia25 mg/d12 wkmalesn = 24
Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men
The Journal of clinical endocrinology and metabolism
Dehydroepiandrosterone increases insulin in humans (+50%).
“were accompanied by a 50% increase in the integrated insulin response (P less than 0.01) without a significant change in fasting glucose insulin or glucose-6-phosphate dehydrogenase values.”
Human trialoral1600 mg/day28 daysfemalesn = 6
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
The Journal of clinical endocrinology and metabolism
Dehydroepiandrosterone showed no clear effect on insulin in humans (WMD: 0.057 μU/mL, P = 0.067).
“DHEA administration did not result in any significant changes in IN (WMD: 0.057 μU/mL, P = 0.067)”
Review
Complementary therapies in medicine
Dehydroepiandrosterone decreases insulin in mice (normal BL/6 mice).
“Four weeks of DHEA treatment initiated at 2 yr of age improved glucose tolerance and at the same time reduced plasma insulin to a "younger" level.”
Animalsnormal BL/6 miceplasma4 weeksfemales
Diabetes
Fasting
downin humans3upin human cells1
4 studies
Fasting
downin humans3upin human cells1
Fasting decreases insulin in obese PCOS and obese control women.
“Insulin and leptin significantly decreased, while insulin sensitivity significantly improved in both groups during fasting.”
Human trialin obese PCOS and obese control women3 daysfemales
Journal of endocrinological investigation
Fasting decreases insulin in humans (obesity).
“During starvation insulinaemia is declining”
Human trialobesityblood2 weeksn = 11
Dehydroepiandrosterone and insulinaemia
Sbornik lekarsky
Fasting decreases insulin in humans.
“The GH increase was associated with decreased insulin and leptin, stimulating lipolysis.”
Review24-48hn = 119
Effect of 24 to 48 hours of fasting on growth hormone levels in healthy adults: a systematic review
SciELO PreprintsPreprint
Fasting induces insulin in human type 1 diabetes pancreatic islets.
“fasting conditions reduce PKA and mTOR activity and induce Sox2 and Ngn3 expression and insulin production”
Cellsin human type 1 diabetes pancreatic isletspancreatic islet
Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes
Cell
High-intensity interval training
downin humans2upin humans1downin mice1
4 studies
High-intensity interval training
downin humans2upin humans1downin mice1
High-intensity interval training increases insulin in humans (overweight postmenopausal women) (p < 0.01).
“Significant within-group increases in irisin (p < 0.01), insulin (p < 0.01), and glucose (p < 0.05) were observed following HIIT.”
Human trialoverweight postmenopausal women20 minfemalesn = 28
Experimental gerontology
High-intensity interval training decreases insulin in humans (15.8 ± 8.1 to 14.0 ± 7.8 uIU/ml).
“HIIT induced a small decrease in SED insulin compared to baseline (15.8 ± 8.1 uIU·ml−1 at baseline and 14.0 ± 7.8 uIU·ml−1 post-HIIT; Cohen's d = 0.23)”
Human trial6 weeksmalesn = 22
Experimental gerontology
High-intensity interval training decreases insulin in the two-hit mouse model of HFpEF.
“Furthermore, HIIT reduced insulin levels without affecting renal function but decreased markers of kidney damage.”
Animalsin the two-hit mouse model of HFpEF5 weeksmales
Life sciences
High-intensity interval training decreases insulin in women with polycystic ovary syndrome (MD -1.88, 95% CI -2.70 to -1.07).
“HIIT significantly improved insulin levels (MD = −1.88, 95% CI: −2.70 to −1.07, p < 0.001)”
Reviewin women with polycystic ovary syndrome
ENDO 2025 abstract
Melatonin
downin humans2no changein humans2
4 studies
Melatonin
downin humans2no changein humans2
Melatonin showed no clear effect on insulin in humans.
“No significant changes were observed for leptin, insulin or markers of glucose homeostasis.”
Human trial1 or 3 mg nightly1 yearfemalesn = 81
Clinical endocrinology
Melatonin decreases insulin in humans (supplementation in adults) (WMD = -1.58 μIU/ml, 95%CI: -2.40 to -0.76).
“insulin (WMD = -1.58 μIU/ml, 95%CI: -2.40 to -0.76, n = 16)”
Reviewsupplementation in adults
Nutrition & metabolism
Melatonin decreases insulin in humans.
“melatonin administration significantly reduced insulin levels”
Review
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Melatonin showed no clear effect on insulin in humans (SMD=-1.03; 95% CI, -3.82, 1.77; p=0.47).
“melatonin administration did not significantly influence insulin levels (SMD=-1.03; 95% CI, -3.82, 1.77; p=0.47; I2: 0.53)”
Review
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Intermittent fasting
downin humans2downin mice1downin rats1
4 studies
Intermittent fasting
downin humans2downin mice1downin rats1
Intermittent fasting decreases insulin in cancer patients undergoing chemotherapy and/or targeted therapies.
“a consistent trend emerged in reduced insulin and IGF-1 levels”
Reviewin cancer patients undergoing chemotherapy and/or targeted therapies
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Intermittent fasting decreases insulin in gynecological and breast cancer patients (SMD -0.395 mU/L, 95% CI -0.674 to -0.116, p = 0.005).
“and insulin concentrations (SMD: -0.395 mU/L; 95% CI: -0.674 to -0.116; p = 0.005).”
Reviewin gynecological and breast cancer patients
BMC cancer
Intermittent fasting decreases insulin in old rats.
“EOD decreased insulin level (p < 0.05 vs. AL) in old animals”
Animalsin old ratsfasting every other day3 monthsmales
Rejuvenation research
Intermittent fasting decreases insulin in mice.
“reduced serum glucose and insulin levels”
Animals
Proceedings of the National Academy of Sciences of the United States of America
Acarbose
downin humans2upin humans1no changein humans1
4 studies
Acarbose
downin humans2upin humans1no changein humans1
Acarbose improves insulin in humans (overweight patients compared with nonoverweight patients).
“Acarbose has been found to improve insulin levels and thus glucose/insulin ratios more effectively in overweight patients compared with nonoverweight patients with PCOS.”
Human trialoverweight patients compared with nonoverweight patientsfemalesn = 74
Fertility and sterility
Acarbose decreases insulin in humans (Postprandial hypotension with autonomic failure; compared with placebo) (Reduction of 11 microU/mL (95% CI 5 to 18; P=0.001)).
“acarbose effectively reduced plasma levels of insulin, a known vasodilator, by 11 microU/mL (95% CI: 5 to 18; P=0.001) compared with placebo.”
Human trialPostprandial hypotension with autonomic failure; compared with placeboplasma100 mg90 minutes after meal intaken = 13
Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure
Hypertension (Dallas, Tex. : 1979)
Acarbose decreases insulin in meals containing carbohydrates.
“acarbose attenuated responses of plasma insulin and glucose-dependent insulinotropic polypeptide (GIP)”
Human trialin meals containing carbohydrates100 mg
American journal of physiology. Gastrointestinal and liver physiology
Acarbose showed no clear effect on insulin in humans (type 2 diabetes; postprandial measurement).
“Postprandial insulin or triglyceride levels were not significantly altered with single dose acarbose treatment.”
Human trialtype 2 diabetes; postprandial measurementsingle dosen = 14
Dose-response profile of acarbose in older subjects with type 2 diabetes
The American journal of the medical sciences
Vitamin D
downin humans3
3 studies
Vitamin D
downin humans3
Vitamin D decreases insulin in humans (MD = −0.30; 95% CI –0.56 to −0.03).
“In terms of decreasing fasting insulin (FIN) level, EHDS (mean difference [MD] = −0.30; 95% CI –0.56 to −0.03) was more effective than control.”
Human trial
Nutrition reviews
Vitamin D decreases insulin in humans (prediabetes) (MD = -0.30, 95% CI -0.56 to -0.03).
“In terms of decreasing fasting insulin (FIN) level, EHDS (mean difference [MD] = -0.30; 95% CI -0.56 to -0.03) was more effective than control.”
Human trialprediabetes≥4000 IU d-1
Nutrition reviews
Vitamin D decreases insulin in humans (polycystic ovary syndrome) (MD -1.98 μIU/mL, 95% CI (-3.32, -0.64) μIU/mL).
“insulin levels[MD=-1.98 μIU/mL, 95% CI (-3.32, -0.64) μIU/mL, P = 0.004]”
Reviewpolycystic ovary syndrome
BMC endocrine disorders
Vitamin D decreases insulin in humans.
“Furthermore, short-term intervention (≤ 6 months) induced a significantly lower level of TG and insulin in comparison to longer duration (> 6 months).”
Review≤ 6 months
Diabetology & metabolic syndrome
Combined aerobic and resistance training
downin humans3
3 studies
Combined aerobic and resistance training
downin humans3
Combined aerobic and resistance training prevents insulin in humans.
“Exercise prevented the insulin rise observed in controls (p = 0.034).”
Human trial12 weeksfemales
Research SquarePreprint
Combined aerobic and resistance training prevents insulin in humans during (neo)adjuvant chemotherapy (p = 0.034).
“Exercise prevented the insulin rise observed in controls (p = 0.034).”
Human trialduring (neo)adjuvant chemotherapy12-weekfemales
Research SquarePreprint
Combined aerobic and resistance training decreases insulin in humans (stage I sarcopenic obesity) (MD = -1.73, p < 0.05).
“Additionally, CE lowered insulin (MD = -1.73, p < 0.05)”
Reviewstage I sarcopenic obesity≥8-week
Frontiers in nutrition
Combined aerobic and resistance training decreases insulin in humans (compared with usual care) (P = .002).
“circulating biomarkers, including insulin ( P = .002), IGF-1 ( P = .001), leptin ( P = .001), and adiponectin ( P = .001), were significantly improved postintervention compared with usual care.”
Reviewcompared with usual carethree times per week, 65% to 85% of heart rate maximum16 weeksn = 100
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Curcumin
downin humans2upin humans1
3 studies
Curcumin
downin humans2upin humans1
Curcumin decreases insulin in overweight/obese women with polycystic ovary syndrome (p = 0.020).
“Serum insulin (p = 0.020) and Quantitative Insulin Sensitivity Check Index (QUICKI) (p = 0.003) were improved significantly”
Human trialin overweight/obese women with polycystic ovary syndrome500 mg/d twice daily6 weeksfemalesn = 60
Complementary therapies in medicine
Curcumin decreases insulin in humans (-26.5%, P = 0.01).
“Pairwise analysis shown mean change in AUC values for insulin was significantly lower only with curcumin (26.5%, P = 0.01) and curcumin + fish oil treatments (25.8%, P = 0.03) but not with fish oil treatment (18%, P = 0.140), when compared with placebo.”
Human trial2 hn = 16
Scientific reports
Curcumin decreases insulin in humans (-26%, P = 0.01).
“Both curcumin (P = 0.01) and curcumin + fishoil (P = 0.03) treatments significantly lowered postprandial insulin (AUC) by 26% in comparison with placebo.”
Human trialtablets120 minn = 16
Scientific reports
Curcumin increases insulin in humans (patients with metabolic syndrome and related disorders) (SMD 0.92; 95% CI, 0.06, 1.78; P=0.036).
“curcumin intake significantly increased insulin levels (SMD 0.92; 95% CI, 0.06, 1.78; P=0.036).”
Reviewpatients with metabolic syndrome and related disordersn = 1,890
Current pharmaceutical design
Walking
no changein humans2downin humans1
3 studies
Walking
no changein humans2downin humans1
Walking decreases insulin in humans (compared with uninterrupted sitting (50SW and 30SW protocols)) (-20.1% (50SW), -18.2% (30SW)).
“insulin tAUC was reduced by 20.1% and 18.2%, respectively (p < .001).”
Human trialcompared with uninterrupted sitting (50SW and 30SW protocols)40-50% HRmax300-minmalesn = 16
Journal of sports sciences
Walking showed no clear effect on insulin in humans.
“whereas no difference was observed for insulin”
Human trialplasma-serum8 hoursn = 12
Acute metabolic responses to breaking up sedentary time in older adults
Physiology & behavior
Walking showed no clear effect on insulin in humans (low-risk, localized PCa) (p > 0.05).
“Analyses showed no changes within or differences in changes between intervention and control groups from baseline to 16 weeks for any biomarker (p > 0.05).”
Human triallow-risk, localized PCa16 weeksmales
Cancer causes & control : CCC
Metformin
downin mice2no changein humans1
3 studies
Metformin
downin mice2no changein humans1
Metformin showed no clear effect on insulin in humans (recently detected type II diabetics).
“Neither treatment altered insulin, c-peptide, or HbA1c.”
Human trialrecently detected type II diabetics5 days
Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients
Clinical and investigative medicine. Medecine clinique et experimentale
Metformin decreases insulin in high-fat diet-induced obese FVB/N mice.
“only a decrease in insulin was observed in metformin-treated HFD mice.”
Animalsin high-fat diet-induced obese FVB/N miceoral250 mg/kg/day
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Metformin decreases insulin in mice.
“Metformin treatment reduced circulating insulin levels in fasting and non-fasting conditions for male mice”
Animalsmales
GeroScience
Ketogenic diet
downin humans3
3 studies
Ketogenic diet
downin humans3
Ketogenic diet decreases insulin in humans (at -5% weight loss).
“VLCKD showed greater reductions in insulin at -5% wt loss (-23% vs -0%, p<0,001)”
Human trialat -5% weight loss
ADA Scientific Sessions 2025 abstract
Ketogenic diet decreases insulin in humans (MD: -2.57 mU/L [95 % CI -4.41 to -0.74], p=0.006).
“KDs were also associated with significantly decreased fasting insulin (MD: -2.57 mU/L [95 % CI -4.41 to -0.74], p=0.006)”
Review1 to 20 weeks
Ageing research reviews
Ketogenic diet decreases insulin in patients with metastatic cancer.
“These approaches have also been shown to improve serum insulin and other metabolic parameters.”
Reviewin patients with metastatic cancer
Insulin-Lowering Diets in Metastatic Cancer
Nutrients
All 133Fewer
Effects
3PhenoAgeAccel
mediatesin humans1
1 study
PhenoAgeAccel
mediatesin humans1
Insulin is linked with PhenoAgeAccel in humans (part of the association between behavioral rhythm scores and PhenoAgeAccel).
“Serum 25(OH)D3 and insulin each significantly mediated part of the association (both P < 0.05).”
Humanspart of the association between behavioral rhythm scores and PhenoAgeAcceln = 4,702
Research SquarePreprint
Alzheimer's disease
no changein humans1
1 study
Alzheimer's disease
no changein humans1
Insulin was not clearly linked with Alzheimer's disease in humans (adjusted regression analyses).
“Serum insulin and related measures were not associated with the level of Alzheimer's disease pathology”
Humansadjusted regression analyses
Annals of neurology
Cognitive function
mediatesin humans1
1 study
Cognitive function
mediatesin humans1
Insulin is linked with cognitive function in humans (mild cognitive impairment).
“lower insulin levels established complete mediation between IF practice and better cognitive function”
Humansmild cognitive impairment36 monthsn = 99
The journal of nutrition, health & aging
Upstream
10Type 2 diabetes
upin humans1downin rats1
2 studies
Type 2 diabetes
upin humans1downin rats1
Type 2 diabetes is linked with higher insulin in DM patients compared with normoglycemic controls.
“All DM patients showed elevated insulin levels than normoglycemic controls.”
Humansin DM patients compared with normoglycemic controlsplasma
Asian Pacific journal of cancer prevention : APJCP
Type 2 diabetes decreases insulin in rats (spontaneous type 2 diabetes model).
“Consequently, plasma insulin levels showed a significant decrease, while plasma glucose, cholesterol and triglyceride levels were increased.”
Animalsspontaneous type 2 diabetes modelmales
Tissue & cell
GHR
upin mice2
2 studies
GHR
upin mice2
GHR increases insulin in mice (shown by adipocyte-specific knockout).
“reduced circulating levels of insulin, c-peptide, adiponectin, resistin”
Animalsshown by adipocyte-specific knockoutplasma
Endocrinology
GHR increases insulin in mice (shown by knockout (GHR -/-)).
“fasting insulin and glucose levels were reduced in the GHR -/- mice but normal in the GHA mice”
Animalsshown by knockout (GHR -/-)
Endocrinology
DNA damage response
downin human cells1
1 study
DNA damage response
downin human cells1
DNA damage response decreases insulin in human cells (growth-arrested EndoC-betaH5 beta cells).
“DNA damage led to decreased levels of CPE and proSAAS, and reduced levels of insulin”
Cellsgrowth-arrested EndoC-betaH5 beta cells
Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells
Diabetologia
CMAH
upin mice1
1 study
CMAH
upin mice1
CMAH increases insulin in mice (shown by knockout, after oral glucose administration) (P < 0.001).
“Unlike glucose, the insulin concentration after oral glucose administration was significantly lower in the Cmah KO group than in the WT group (P < 0.001).”
Animalsshown by knockout, after oral glucose administration
Geriatrics & gerontology international
FGF21
upin mice1
1 study
FGF21
upin mice1
FGF21 increases insulin in mice (shown by liver-specific knockout in ovariectomized mice).
“Mechanically, we found that FGF21 LKO reduced circulating insulin levels”
Animalsshown by liver-specific knockout in ovariectomized micefemales
International journal of molecular sciences
Muscle mass
downin humans1
1 study
Muscle mass
downin humans1
Muscle mass is linked with lower insulin in humans (β = -0.40; 95% CI: -0.79, -0.01).
“Women with low muscle mass had higher levels of insulin (uIU/mL; β = -0.40; 95% CI: -0.79, -0.01)”
Humansfemalesn = 74
PloS one
Weight gain
upin humans1
1 study
Weight gain
upin humans1
Weight gain is linked with higher insulin in humans (+24% vs -10%).
“In 566 individuals with ≥+3% weight gain vs 561 with weight change ≤-3%, divergent patterns were observed for insulin (+24% vs -10%)”
Humans
Longitudinal profiling of metabolic ageing trends in two population cohorts of young adults
International journal of epidemiology
SIRT4
downin mice1
1 study
SIRT4
downin mice1
SIRT4 decreases insulin in mice (glucose-stimulated).
“we found SIRT4KO mice consistently had elevated glucose- and leucine-stimulated insulin levels in vivo”
Animalsglucose-stimulated
Journal of inherited metabolic disease
FOSB
downin mice1
1 study
FOSB
downin mice1
FOSB decreases insulin in mice.
“suppresses insulin secretion”
Animalsventral hypothalamus
Hypothalamic ΔFosB prevents age-related metabolic decline and functions via SNS
Aging
Older age
upin humans1
1 study
Older age
upin humans1
Older age increases insulin in humans (fed state) (50% higher than young subjects).
“the older subjects had a 50% higher concentration than the young subjects in the fed state (p < 0.05)”
Human trialfed stateplasma30 g whey protein30 min after protein ingestion
Nutrients
Associations
64Metabolic syndrome
upin humans2OR 1.25
2 studies
Metabolic syndrome
upin humans2OR 1.25
Insulin predicts metabolic syndrome in humans (Diagnostic classification) (AUC 0.998).
“and an AUC of 0.998 for insulin.”
HumansDiagnostic classificationserum
Journal of Associated Medical Sciences
Insulin predicts metabolic syndrome in humans (AUC: 0.773 (0.653-0.893)).
“AUC: 0.773 (0.653-0.893) and 0.783 by cross validation and bootstrapping samples for MetS risk”
Humans
Nutrients
Insulin is linked with a higher risk of metabolic syndrome in humans (adjusted models) (OR: 1.25 (1.09-1.43)).
“in adjusted models it was found to be associated with at least two CM risk factors and MetS risk (OR: 1.87 (1.24-2.83) and OR: 1.25 (1.09-1.43)) respectively”
Humansadjusted models
Nutrients
Cognitive function
downin humans2
2 studies
Cognitive function
downin humans2
Insulin is associated with cognitive function in humans (post-exercise in obese-IGT adults).
“Greater insulin levels in Obese-IGT post-exercise also negatively correlated with changes in cognitive function following exercise (p < 0.01).”
Human trialpost-exercise in obese-IGT adults
Physiology & behavior
Insulin is associated with cognitive function in humans (adjusted regression analyses).
“higher insulin and leptin levels, and lower adiponectin and receptors for advanced glycation-end products levels, respectively, were each associated with lower levels of global cognition.”
Humansadjusted regression analyses
Annals of neurology
Dietary restriction
upin humans1mixedin rats1
2 studies
Dietary restriction
upin humans1mixedin rats1
Dietary restriction is associated with insulin in rats.
“Significantly changed insulin content in the hippocampus, together with altered insulin signaling were found under the influence of DR”
Animalshippocampusmales
Dietary restriction alters insulin signaling pathway in the brain
BioFactors (Oxford, England)
Dietary restriction predicts insulin in humans.
“validated the changes of insulin, IGF-1 and IGFBP-1,2 to monitor DR effects”
Review
Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human
Aging
CDKN1A
upin humans1downin humans1
2 studies
CDKN1A
upin humans1downin humans1
Insulin is associated with CDKN1A in validation cohort.
“By using transcriptomic data from the KOBS study, we could validate the association of insulin with p21 in the liver.”
Humansin validation cohortlivern = 180
Diabetes
Insulin is associated with CDKN1A in humans (regression model) (B = -0.065, p = 0.026).
“The p21 gene expression was inversely associated with circulating insulin (B = -0.065, p = 0.026) and C-peptide levels (unadjusted B = -0.097, p = 0.014; adjusted B = -0.133, p = 0.003).”
Humansregression modelleucocytesn = 210
Indian journal of pediatrics
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 1.04
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 1.04
Insulin predicts metabolic dysfunction-associated steatotic liver disease in humans (predicting NAFLD) (AUC 0.774, 95% CI 0.757-0.792).
“serum insulin had good discriminative ability for predicting NAFLD, with an area under the curve of 0.774 (95% CI: 0.757-0.792)”
Humanspredicting NAFLDn = 2,791
Medicine
Insulin is linked with a higher risk of metabolic dysfunction-associated steatotic liver disease in humans (continuous variable, adjusted for covariates) (OR 1.04, 95% CI 1.01-1.07).
“serum insulin levels treated as a continuous variable were significantly associated with increased odds of having NAFLD (odds ratio [OR] = 1.04; 95% confidence interval [CI]: 1.01-1.07; P = .014)”
Humanscontinuous variable, adjusted for covariatesn = 2,791
Medicine
More on Metabolic dysfunction-associated steatotic liver disease
SHBG
downin humans1
1 study
SHBG
downin humans1
SHBG is associated with insulin in humans (β = −7.5030).
“A significant inverse association was observed between insulin and SHBG [effect estimate (β) = −7.5030, p = 0.0010;; ].”
Human trialfemalesn = 10
Frontiers in nutrition
SHBG is associated with insulin in humans (p = 0.0010).
“SHBG was significantly and inversely associated with insulin (p = 0.0010), insulin resistance score (HOMA-IR; p = 0.0012)”
Human trialfemalesn = 10
Frontiers in nutrition
Pittsburgh Sleep Quality Index
upin humans1
1 study
Pittsburgh Sleep Quality Index
upin humans1
Pittsburgh Sleep Quality Index is associated with insulin in humans (university students).
“Insulin was positively correlated with the PSQI score”
Humansuniversity studentsn = 243
Sleep quality, social jet lag, and cardiovascular risk factors in young adults
Frontiers in public health
Reverse-transformed empirical dietary inflammatory index
downin humans1
1 study
Reverse-transformed empirical dietary inflammatory index
downin humans1
Reverse-transformed empirical dietary inflammatory index is associated with insulin in humans (beta -0.086 (95% CI -0.130, -0.043)).
“insulin [-0.086 (-0.130, -0.043)]”
Humansquantile regression at the median of each biomarker distribution, adjusted for sociodemographic and lifestyle factors1 standard deviation increment in adherencen = 1,769
Biological signature of dietary patterns in older adults: findings from a population-based study
BMC medicine
More on Reverse-transformed empirical dietary inflammatory index
Social jetlag
upin humans1
1 study
Social jetlag
upin humans1
Social jetlag is associated with insulin in humans (p < 0.05).
“Participants with SJL had significantly higher Body Mass Index (BMI), waist and hip circumference, body fat mass (BFM), and insulin levels (p < 0.05).”
Humansn = 223
Relationship between genetic risk, social jetlag, and obesity traits in a Turkish adult population
Chronobiology international
Old age
upin E. caballus1
1 study
Old age
upin E. caballus1
Old age is associated with insulin in E. caballus during graded exercise test after 8 weeks of training (GXT2).
“Young horses had lower plasma insulin concentrations than old horses during GXT2 (P = 0.005), but not during GXT1.”
Animalsduring graded exercise test after 8 weeks of training (GXT2)plasma8 weeksfemales
Journal of equine veterinary science
Chenopodium quinoa-based functional formulation
mixedin humans1
1 study
Chenopodium quinoa-based functional formulation
mixedin humans1
Chenopodium quinoa-based functional formulation is associated with insulin in humans.
“Interaction plots revealed significant effects depending on the product consumed and the intervention period for insulin, triglycerides, APOA, and monocytes' phenotype.”
Human trial12 days
Molecular nutrition & food research
Change in insulin sensitivity
upin humans1
1 study
Change in insulin sensitivity
upin humans1
Insulin is associated with change in insulin sensitivity in humans (diet-induced weight loss group, pre-intervention measure) (r = 0.60).
“Pre-intervention measures of insulin (r = 0.60) and HOMA-IR (r = 0.56) were associated with change in insulin sensitivity (C_IS) in the WL group”
Human trialdiet-induced weight loss group, pre-intervention measure6 months
Frontiers in endocrinology
ADIPOQ
downin humans1
1 study
ADIPOQ
downin humans1
ADIPOQ is associated with insulin in humans (GG genotype of rs1501299, after Diet P) (GG -3.2±1.0 mU/L vs GT±TT -0.6±0.4 mU/L: p=0.01).
“After Diet P, only subjects with GG genotype showed a significant improvement in the insulin levels”
Human trialGG genotype of rs1501299, after Diet P12 weeks
European review for medical and pharmacological sciences
SREBF1
mixedin humans1
1 study
SREBF1
mixedin humans1
SREBF1 is associated with insulin in humans.
“The three tSNPs (rs12953299, rs4925118 and rs4925115) were associated with differences in the response of plasma insulin levels (p = 0.01, p = 0.005 and p = 0.004, respectively)”
Human trial5 g/day6-weekn = 210
SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation
Lipids in health and disease
Cerebral metabolic rate of glucose
downin humans1
1 study
Cerebral metabolic rate of glucose
downin humans1
Insulin is associated with cerebral metabolic rate of glucose in humans.
“Higher plasma triglyceride levels and higher plasma insulin levels were associated with lower CMRg in several regions”
Human trialbrain
Brain and systemic glucose metabolism in the healthy elderly following fish oil supplementation
Prostaglandins, leukotrienes, and essential fatty acids
All 64Fewer
Funding
182 grants since 2016National Institute of Diabetes and Digestive and Kidney Diseases$54.4MNational Institute on Aging$43.2MNational Heart, Lung, and Blood Institute$18.2M
Sleep loss and circadian misalignment - mechanisms of Insulin Resistance
National Heart, Lung, and Blood InstituteLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center$693K2025–2029
Testing a blood fatty acid algorithm as an earlier and easier predictor of insulin resistance
National Institute of Diabetes and Digestive and Kidney DiseasesOmegaquant Analytics$1M2023–2028
National Institute on AgingMayo Clinic Rochester$1.7M2026–2031
The effects of a sleep extension intervention on insulin sensitivity in habitual short sleepers
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Utah$43.7K2026–2028
National Institute on Minority Health and Health DisparitiesSalimetrics$214K2026–2027
National Institute of Diabetes and Digestive and Kidney DiseasesVanderbilt University Medical Center$332K2024–2027
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
National Institute on AgingMayo Clinic Rochester$675K2019–2029
Effect of SPTLC3 on aging- and diet-induced insulin resistance and atherosclerosis
National Heart, Lung, and Blood InstituteSuny Downstate Medical Center$800K2026–2030
National Heart, Lung, and Blood InstituteUniversity of Iowa$38.9K2025–2028
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
National Cancer InstituteNew York University School of Medicine$523K2024–2028
How this record changed
Summary rewritten as its findings changed.
As it read before
Insulin is associated with cellular senescence in human liver and frailty in dogs. Mouse studies report decreases with caloric restriction, but increases in female TejJ89 and TejJ114 mice. Human trials report decreases with exercise in older women with sarcopenic obesity; acarbose reduces insulin in postprandial studies but shows no change in a trial in non-insulin-dependent diabetes.
Summary rewritten as its findings changed.
As it read before
Pre-pregnancy overweight/obesity is associated with insulin at six months postpartum in a human study of women. A separate human study reports lower insulin with an anti-inflammatory diet; a review describes reductions with high-frequency exercise interruptions.
Summary written from the findings.